Huddlestock Fintech AS · OSL:HUDL
Huddlestock Fintech AS — Q3 2022 Earnings Presentation
30 slides from Huddlestock Fintech AS's earnings presentation, 2022
Slide 1: Q3 2022 Investor Presentation
!"#$#%&'&()%*)+*,-(".*/0'"&#"*'%.*1(%#*2)%&-$*3433*"#$05&$ !"#$%&'()'*#+"++ 6#7)8"'&(9(%:*;'<(&'5*2'"=#&$
Slide 2: Disclaimer and forward-looking statements
!"#$%&"'()*)(*+,)-&).*%,,/"01*#2&2('(02# !"#$%&"'() )( *+),&)- %++."/0 #1&1('(/1# 23"# 4)(#(/1&1"+/ #4(&.# +/%5 &# +* 13(") -&1(6 &/- 13( 7"(,# (84)(##(- &)( #9:;($1 1+ $3&/0( :&#(- +/ & /9':() +* *&$1+)#6 "/$%9-"/06 ,"13+91 %"'"1&1"+/6 '&$)+($+/+'"$ &/- (<9"15 '&).(1 $+/-"1"+/#6 "/7(#1+) &11"19-( &
Slide 3: Agenda
!"##$%&'()*+,-.'%)/ !"#$%&'()*)+,-'%%"..-($-%'/)('0-#'&1"(. 4567$8%9"6:*$8 !"#$%&'%()*+,- 2#*7/-*$ ./"01%2&3 3
Slide 4: Q3 2022 highlights
3"14%"142#*"0*56*7877 ,-../'01%23#4*5.'*#6%'0#/7&'8## $9%*.#:*%-;#5<<%-<2'0#<'=#2%*<'*#01%<'#7<&'01('<18 • >?#@%<0%/7.51'.#:*%-;#A'&'<-'0#%B#$CD#!!8EF#(7//7%<G#5<#7<2*'50'#%B#HI?J#K%K8 • ,-../'01%23#4*5.'*#6%'0#/7&'#=71L#M%/5*70#5<.#4%(%**%=#N5<38 • O7<<7<6#<'=#2/7'<10G#6*%=7<6#'P7017<6#(5<.51'0Q •
Slide 5: Strategy and growth outlook
9(:*;)",)"2"(# ]'(%2*517\'#522'00#1%#25;715/#(5*3'108# ]'/7&'*#7<<%&517&'#1'2L<%/%6U#0%/-17%<0#B%*#1L'#4*5.'#5<.#O'5/1L4'2L#7<.-01*7'08 ]'/7&'*7<6#0L5*'L%/.'*#&5/-'#1L*%-6L#01*51'672#6*%=1L#%;;%*1-<717'0^ • _*7%*717\'#;*%B715)/'#6*%=1L#5<.#*'2-**7<6#*'&'<-'08 • X<1'6*517%<#5<.#.'/7&'*U#%B#0U<'*67'0#
Slide 6: Q3 2022 revenue growth
A,0#,%".&2(.*)(B(0C(#*"0*56*7877* ]'/7&'*7<6#01*%<6#K%K#*'&'<-'#6*%=1LG#51#5#6*%=1L#*51'#%B#HI?J !"#"$%"& '()*+, 2$('0-345)(6 !!"#$ %&"'($ !)'"&$ $CD $CD $CD !"#$%#&'()*+( revenues and EBITDA include F5 IT from 1 May 2022, and NOK 3.24 million development costs previously booked as an expense in the
Slide 7: Proforma revenue Q3 2022
D),+,)'&*)(B(0C(#*"0*E?*7877* M25/7<6#-;#B%*#B-1-*'#6*%=1L#5<.#;*%B715)7/71U#=71L#1*5<0B%*(517%<5/#7<&'01('<108 !"#"$%"& '()*+, 2$('0-345)(6 *#"*$ %'"($ !)'"&$ $CD $CD $CD !Proforma revenues include F5 IT, Trac Services and Tracs Technology from 1st January 2022. 7
Slide 8: Share price and volume YTD 2022
F4&)(;)"$(*E?*7877 Average daily traded volume of shares YTD @%<17<-7<6#1%#%-1;'*B%*(#;''*08 321,267 210,630 in 2021 HUDLLESTOCK FINTECH: SHARE PRICE AND VOLUME YTD 2022 HUDLESTOCK SHARE PRICE YTD 2022 110 VS FIRST NORTH ALL SHARE AND FIRST NORTH TECHNOLOGY 4,0 110 HUDL FIRST NORTH ALL-SHARE FIRST N
Slide 9: Shareholders
GH,).*I),C;*&*0(-*$,)0()#2,0(*"0B(#2,)= !"#$ %&"'(&)*+(', -).,&"'(, /.,&"'(, R0#%B#!!" $%&'()'*#+"++ 0 123345%6789.:;-6581.<% = >?> =@A BC@@/ D E;%;7-.;-E5%6.%6<E<-F5! = D=B A0@ BC>>/ D 123345.<% B>= @DB GC@G/ ? H<-9.I24;2%.H<5! A A0@ @?? @CJJ/ ,-../'01%23#&5/7.51'.#=71L#7<&'01('<1#B*%(#2%*<'*#01%<'
Slide 10: Business update
0'12'%3-)+"4#2'% 1
Slide 11: Company overview and vision
!"#$%"&$'()*')+$','-$,#)$'-#./$*' 75&-/5&/$."8 a(;%='*7<6#%-*#2/7'<10#1%#.'/7&'*#522'00#1%#6/%)5/#25;715/# JC)*B"#",0K (5*3'10#1L*%-6L#07(;/'G#522'007)/'G#5<.#;'*0%<5/7\'.#1*5.7<6# 5<.#7<&'017<6#0%/-17%<08 L(#4&;"01*+"0&0$"&%*'&)/(2# 95::0".($%1-.$05()$+. 24),C14* X<<%&517&'#f T%.-/5*#S @%//5)%*517&
Slide 12: Creating shareholder value
M&%C(*$)(&2",0*24),C14*&$$)(2"B(*?NO @*'517<6#0L5*'L%/.'*#&5/-' • R#2%*'#;7//5*#%B#,-../'01%23b0#01*51'6U#70#1%#2*'51'#0L5*'L%/.'*#&5/-'# 1L*%-6L#522*'17&'#52Z-70717%<08 • C-*#T`R#01*51'6U#70#B%2-0'.#%<#15*6'10#=L'*'#='#B7<.#076<7B725<1# 0U<'*67'0#5<.#0-;;%*10#,-../'01%23b0#g1'2L<%/%6U#B7*01g#f B%2-
Slide 13: Client onboarding and trading flow
3,-*"2*&%%*+"2#*2,1(24()*#2)&2(1"$&%%: Clients XYZ Onboard Clients Trade global markets and funds Real time reporting and settlement H9)I(84()1"#(I"#I4911"/0I"1I&%%I1+0(13()>IIJ+9I$&/I3&7(I#+'(I+*I"1I+)I&%%I+*I"1> Investor Services, Trade and Wealth Tech Solutions Expert Consultants and Technology D
Slide 14: Platform and products
F"';%"+:"01 ,C) ;),.C$2 ;,)2+,%", &# ;&)2 ,+ 1&"0"01*#:0()1"(# =9--%(#1+$.I2)&-()I"#I&IK3"1(IL&:(%I2)&-"/0I?FD> ?I*%(8":%(6I'+-9%&)I1)&-"/0I Canyon 9088:,>@"<)%;/*8,/ #+%91"+/6I(&#"%5I"/1(0)&1(-I&%+/0#"-(I&%)(&-5G(8"#1"/0I$%"(/1I#()7"$(#I7"&I?FD#> Operation Center Eqytech 9088:,>@"<)%W,*:@#%X*$*=,/
Slide 15: Strategic goals 2027
JC)*#2)&2(1"$*1,&%#*P -4()(*&)(*-(*"0*>*:(&)#*+),'*0,-Q M1*51'672#6%5/0^## X<#E#U'5*0#17('#='#=5<1#1%#)'#5#=%*/.#2/500#1'2L<%/%6U#;*%&7.'*# .'/7&'*7<6 7<<%&517&'#5<.#0-0157<5)/'#1'2L<%/%6U#5<.#2%(;/75<1# 0%/-17%<0#1%#1L'#25;715/#(5*3'10G#1*'50-*U#5<.#='5/1L (5<56'('<1# 7<.-01*7'08# 2022 2027 R1)&1(0
Slide 16: Board of directors
RS;()"(0$(.*T,&).*,+*!")($2,)# $9%*.#:*%-;#5;;%7<10#1=%#<'=#)%5*.#('()'*08 >6?)+:-9$?0'+:@--./012/$3 H'#()+ D'()+@ (4/15 6"27"1 @A;B<C B> & >:"B&D :<E":F":<:=" GBEH %#": EH&< IJ A:&"> 9&%EB< /&EB< B> W:&C #$ *<<#;&EB#< &E QF&":N&<Y 4 Q93)&<Y5 #$ :KF:"B:<L: B< >E&"EB<M &<C >L&DB<M L#%F&<B:> B< W: H&>
Slide 17: Financials
56 2.# 7+8(.'/&+9:99+;%&"$'& 1
Slide 18: Group revenues Q3 2022
I),-"01*$%"(02*)(B(0C(#*"0*E?*7877*P L(;,)2(.*$,0#,%".&2(.*)(#C%2#* ]'/7&'*7<6#7<#@%<0-/17<68#X<&'017<6#7<#2/7'<1#.'/7&'*7'0#5<.#*'2-**7<6#*'&'<-'#01*'5(0#7<#4'2L<%/%6U8 !"8419"5:!"#"$%"& !"8419"5:'()*+, 2$('0-345)(6 ()"+$ %,"*$ !)'"&$ $CD $CD $CD 18
Slide 19: Group revenues
I),C;*L(B(0C(# ]'/7&'*7<6#5<.#7<&'017<6#7<#01*51'672#1'2L<%/%6U#0%/-17%<0 • :*%-;#A'&'<-'0#FT#$CD#?+8dd(#H+?FJ#K%K8 ;14%8 1"#"$%"&:<=>?:@AAAB • _*%B%*(5#:*%-;#A'&'<-'0#FT#$CD#eE8e"([#HeFJ#K%K8 • 4'2L<%/%6U#f $'=#2/7'<1#6%'0#/7&'^ • H7/>@%<:7,$@>%="%:76,%"$%9088:,>@"<)B>%;/*8,;,<#%1:*@G"/-' • Z,*87$=
Slide 20: Group costs
I),C;*A,#2# 476L1'*#/5)%-*#(5*3'108##X<&'017<6#7<#1'2L<%/%6U8 ;14%8:>8"1/90$C:-4&9&:<=>?:@AAAB • :*%-;#@%010#FT#$CD#ed8de(#H!!!J#K%KG#7<2/-.'0#$CD# h(#.';*'27517%<8 • _*%B%*(5#:*%-;#@%010#FT#++#$CD#he8eE([#HEhJ#K%K8 • _'*0%<<'/#2%01#$CD#+F8"!(#51#FT#++8 • (@/"$=%8,-*$8%G/"-%,$8%<:7,$@>%@/*$>:*@7$=%7
Slide 21: Group EBITDA
I),C;*RTUV!O C;17(7\7<6#7<1'*<5/#*'0%-*2'08##@%<157<7<6#2%010#=L7/'#6*%=7<6#*'&'<-'08 • :*%-;#FT#aNX4]R#$CD#Sh8e?( ;14%8 '()*+,:<=>?:@AAAB • _*%B%*(5#:*%-;#FT#aNX4]R#$CD#Sd8?"( • :*%-;#A'&'<-'0#$CD#?+8dd(G#H+?FJ#K%K^ • H7/>@%<:7,$@>%="%:76,%"$%9088:,>@"<)%;/*8,/%1:*@G"/-' • ;A"%$,A%<:7,$@%<"$@/*<@>%
Slide 22: Delivery and client wins
V($40,%,1: R#01%*U#%B#1=%#L5/&'08##@%<17<-'.#B%2-0#%<#2/7'<1#.'/7&'*7'0#5<.#6*%=7<6#*'2-**7<6#*'&'<-'#01*'5(08 :%7<6#/7&'#=71L#B7*01#(59%*#2/7'<1#7<#:'*(5<U#7<#>?#++8 • A';%*1'.#*'&'<-'0#%B#$CD#e8IE(#7<#FTG#H!EIJ#K%K8 *"D.$4E4CF:1"#"$%"&:<=>?:@AAAB • :'*(5<U#f W7*01#2/7'<10#5*'#/7&'#=71L#,-../'01%23
Slide 23: Order book and outlook
A,0#C%2"01 M1*%<6#.'/7&'*U#B*%(#'P;'*1#5.&70%*0#7<#M='.'<#5<.#]'<(5*3#.'0;71'#176L1#/5)%-*#(5*3'108 W-<.5('<15/0#*'(57<#01*%<6#7<#>?#++ G0&0C4$:'H8"19:-4$&%E9/$9&:<=>?:@AAAB • A';%*1'.#*'&'<-'0#%B#$CD#+d8hF(#51#FTG#H?J#K%K8 • j5*6'#M='.70L#)5<37<6#7<0171-17%<#'P1'<.0#5<.#.'';'<0# ;*%;*7'15*U#k1*US5<
Slide 24: Appendix
<..%=%& 2
Slide 25: Consolidated income statement
A,0#,%".&2(.*U0$,'(*F2&2('(02*WL(;,)2(.*&0.*;),+,)'&X*
Slide 26: Balance Sheet
Balance Sheet Consolidated Financial Position (in NOK) 30.09.2022 30.06.2022 _ 31.12.2021 [i Consolidated Financial Position (in NOK) ASSETS EQUITY Intangible assets Paid-in capital Research and development 34968074 28304621 23333391 Share capital 244612 244612 244 612 Goodwill 54486938 53262862 424
Slide 27: Cash Flow Statement
Cash Flow Statement nsolidated Statement of Cash Flows (in NOK) Q32022 92022 12022 2021 Cash flows from operating activities Profit (loss) before tax -3969521 -16 104 874 -12 135 353 -20 282.245 Depreciation and amortisation 3516529 9520925 6004 396 10594597 Net result discontinued operations 0 0 0
Slide 28: Contacts
J$6,>@"/%/,:*@7"$>%<"$@*<@>O U#H<'(5'QY&[:% V"#=F'O(1 [:>]H=CCD:>E#LY5L#% ^?_'?4`'`_'?4I -<C:">'!:B<:"E Award-winning platform V"#=F'OZ1 &F]H=CCD:>E#LY5L#% ^?_'.7?'_.'a7? O:LBDB&'b="&> (K:L=EB;:'-C;B>#" L#D]H=CCD:>E#LY5L#% ^?_'.J4'?J'7`I' Listed on Images & Photography: unsplash.com and pixabay.com
Slide 29: Disclaimer
YC%%*."#$%&"'() Z=DD'CB>LD&B%:" +HB> F":>:<E&EB#< H&> N::< F":F&":C NA W=CCD:>E#LY ZB<E:LH -Q cEH: W=CCD:>E#LYd >#D:DA $#" EH: =>: &E EH: F":>:<E&EB#<> E# B<;:>E#"> H:DC B< L#<<:LEB#< GBEH EH: F":>:<E&EB#< #$ EH: F&>E ":>=DE> #$ EH: L:"E&B< F:"B#C &<C &<EBLBF&E:C $=E=": F:"$#"%&<L:5 +HB> F":>:<E&EB#
Slide 30: Disclaimer continued
YC%%*."#$%&"'()*$,02"0C(. Z=DD'CB>LD&B%:"'L#<EB<=:C -<A >E&E:%:<ES :>EB%&E: #" F"#[:LEB#<> B<LD=C:C B< EHB> F":>:<E&EB#< c#" =F#< GHBLH &<A #$ EH: L#<LD=>B#< L#<E&B<:C H:":B< &": N&>:Cd GBEH ":>F:LE E# &<EBLBF&E:C $=E=": F:"$#"%&<L: cB<LD=CB<MS GBEH#=E DB%BE&EB#<S &<A >E&E:%:<ES :>EB%&E: #" F"#[:LEB